Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for obsessive symptoms in bipolar disorder
IRCT20240601061976N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obsessive compulsive disorder (OCD) and bipolar disorder (BD) comparing Memantine adjunct arm with Placebo adjunct arm (2 arms). Primary endpoints: Obsession score and Side effects. Started Jun 2024; status: completed.
02
Drugs
memantine
03
Conditions
obsessive compulsive disorder (OCD)bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20240601061976N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240601061976N1.